Regeneron · 2 days ago
Senior Associate Scientist- Bioassay
Regeneron is seeking an experienced and motivated Senior Associate Scientist to join the Bioassay team as a part of their Therapeutic Proteins Department. The role involves developing cell-based functional assays to identify and characterize therapeutic antibodies while collaborating across functions to meet project achievements.
BiopharmaBiotechnologyPharmaceutical
Responsibilities
Culturing mammalian cells and engineering cell lines via transfection, transduction and CRISPR
Characterizing cells and reagents by flow cytometry, immunocytochemistry and immunoblotting
Developing cell-based bioassays and using them to screen antibodies in 96-well and 384-well plate formats
Analyzing data and troubleshooting experiments
Maintaining accurate and reliable records including electronic notebooks and all other pertinent documentation
Presenting data in small and large group settings
Qualification
Required
BS/MS with a minimum of 3-5+ years of relevant experience
Experience with mammalian cell culture
Experience with cell engineering and validation
Experience with cell-based assay development
Ability to work collaboratively
Ability to multi-task with attention to details
Excellent verbal and written communication skills
Preferred
Experience with flow cytometry
Experience with high throughput assays
Experience with therapeutic antibody development
Experience with primary immune cell assays
Experience with effector function assays
Benefits
Health and wellness programs
Fitness centers
Equity awards
Annual bonuses
Paid time off for eligible employees at all levels
Company
Regeneron
Regeneron Pharmaceuticals specializes in the discovery, development, and commercialization of innovative medicines.
H1B Sponsorship
Regeneron has a track record of offering H1B sponsorships. Please note that this does not
guarantee sponsorship for this specific role. Below presents additional info for your
reference. (Data Powered by US Department of Labor)
Distribution of Different Job Fields Receiving Sponsorship
Represents job field similar to this job
Trends of Total Sponsorships
2025 (157)
2024 (128)
2023 (128)
2022 (137)
2021 (104)
2020 (122)
Funding
Current Stage
Public CompanyTotal Funding
$15.93MKey Investors
U.S. Department of Health & Human Services
2024-07-11Post Ipo Equity· $2.03M
2023-10-18Post Ipo Equity· $5M
2016-08-22Post Ipo Equity· $8.9M
Leadership Team
Recent News
2026-01-09
2026-01-08
Company data provided by crunchbase